ZyVersa Therapeutics
(OTC) ZVSA
ZyVersa Therapeutics Financials at a Glance
Market Cap
$1.94M
Revenue (TTM)
$26.08K
Net Income (TTM)
$25.70M
EPS (TTM)
$-5.05
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
0.32 (Low)
Dividend
$0.00
Beta (Volatility)
0.32 (Low)
Price
$0.24
Volume
9,578
Open
$0.24
Price
$0.24
Volume
9,578
Open
$0.24
Previous Close
$0.24
Daily Range
$0.24 - $0.26
52-Week Range
$0.11 - $1.94
Dividend
$0.00
Beta (Volatility)
0.32 (Low)
Price
$0.24
Volume
9,578
Open
$0.24
Previous Close
$0.24
Daily Range
$0.24 - $0.26
52-Week Range
$0.11 - $1.94
ZVSA News
ZVSA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ZyVersa Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
Stephen C. Glover
Website
www.zyversa.comHeadquarters
Weston, FL 33326, US
ZVSA Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-956443%
Net Income Margin
-985%
Return on Equity
-113%
Return on Capital
2127%
Return on Assets
-25%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.94M
Shares Outstanding
8.10M
Volume
9.58K
Short Interest
0.00%
Avg. Volume
76.18K
Financials (TTM)
Gross Profit
$6.93K
Operating Income
$9.14B
EBITDA
$9.14B
Operating Cash Flow
$7.56M
Capital Expenditure
$3.00
Free Cash Flow
$7.56M
Cash & ST Invst.
$1.53M
Total Debt
$0.00
ZyVersa Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$1.94M
N/A
Market Cap/Employee
$277.57K
N/A
Employees
7
N/A
Net Income
$19.81M
-724.8%
EBITDA
$20.53M
-805.1%
Quarterly Fundamentals
Net Cash
$527.98K
+329.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-24.70%
N/A
Return on Invested Capital
2127.16%
N/A
Free Cash Flow
$1.41B
+54.3%
Operating Cash Flow
$1.41B
+77.8%